drugset

drugset / Trial / NCT02150447

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

NCT02150447 ↗

Phase 3 Terminated 394 enrolled National Cancer Center, Korea Gyeongsang National University Hospital · collab Kosin University Gospel Hospital · collab Pusan National University Hospital · collab

RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is the effect of proton pump inhibitor (PPI) with respect to gastric cancer bleeding in inoperable patients.

Timeline

Start: 2009-06
Primary completion: 2015-04
Completion: 2017-05

Publications

Kim YI, Kim MJ, Park SR, Kim HK, Cho SJ, Lee JY, Kim CG, Kim GH, Park MI, Nam BH, Park YI, Choi IJ. Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. J Gastric Cancer. 2017 Jun;17(2):120-131. doi: 10.5230/jgc.2017.17.e15. Epub 2017 May 31.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Lansoprazole	Other / unclassified	30 mg	Oral

Indications